Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis

Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis (MERLOT)

This post-market study aims to compare health outcomes for Chronic Rhinosinusitis (CRS) patients treated with balloon sinus dilation (BSD) versus continued medical management.

Inclusion Criteria:

• Males and females aged 19 or greater
• Diagnosis of Chronic Rhinosinusitis (CRS)
• Failure of appropriate medical management
• Radiographic evidence of inflammation of the paranasal sinuses
• Surgical candidate
• Willing and able to read and sign the Informed Consent Form and remain compliant with the protocol and study procedures
• Able to read and understand English

Exclusion Criteria:

• Not suitable for balloon dilation for all peripheral sinuses that require treatment
• Clinically significant illness that may interfere with the evaluation of the study
• Patients involved in other clinical studies 30 days prior to study
• Pregnant or lactating females
• Patients unable to adhere to follow-up schedule or protocol requirements